access intranet after hours circle-arrow apply blog caret circle arrow close closer look community outreach community outreach contact contact us down arrow facebook lock solid find a provider find a clinical trial find a provider find a researcher find faculty find-a-service how to apply join leadership left arrow locations logo make a gift map location maximize minimize my chart my chart notification hp notification lp next chevron right nxt prev pay your bill play previous quality and safety refer a patient request a speaker request appointment request an appointment residents corner rss search search jobs Asset 65 submit a story idea symptom checker Arrow Circle Up twitter youtube Dino Logo External Link University Logo Color University Logo Solid Health Logo Solid Arrow Right Circle Book Calendar Date Calendar Search Date Diploma Certificate Dollar Circle Donate Envelope Graduation Cap Map Pin Map Search Phone Pills Podcast

Information for Postdocs

T32: Integrative Training in Oncogenic Signaling

The Hollings Cancer Center seeks applications for the NCI-funded Ruth L. Kirschstein National Research Service Training Grant’s (T32) Integrative Training in Oncogenic Signaling (ITOS) Program. The goals of the program are to provide five postdoctoral trainees with proactive mentoring, oversight, and research training in cutting-edge methodology; to develop useful academic and essential career development skills; to foster collaborative, interdisciplinary interactions with faculty and other trainees; and to provide exposure to current cancer research discoveries and how these are being translated into novel approaches to prevention, diagnosis, and treatment of cancer. The ITOS Program, led by an outstanding cadre of program Faculty, offers distinct experiences, and opportunities only afforded to the selected ITOS Fellows.

T32 Program in Immunology Research & Entrepreneurship (PIRE)

The Program in Immunology Research and Entrepreneurship (PIRE) was developed to train postdoctoral fellows in immunology with an emphasis on translation, biomedical innovation and entrepreneurship. The program seeks to address the need to empower our future immunology research workforce with the competencies necessary to commercialize scientific discoveries. Disease-related themes that are central to this program are innate immune mechanisms, immunity to infection, alloimmunity (organ and hematopoietic stem cell transplant), autoimmunity, and cancer immunology.